Anuh Pharma Ltd (ANUHPHR) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 506260 | NSE: ANUHPHR | Pharmaceuticals & Drugs | Small Cap

Anuh Pharma Share Price

82.37 3.21 4.06%
as on 05-Dec'25 14:26

Anuh Pharma Ltd (ANUHPHR) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 506260 | NSE: ANUHPHR | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Anuh Pharma

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Anuh Pharma stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
20.49
Market Cap:
793.4 Cr.
52-wk low:
74
52-wk high:
121

Is Anuh Pharma Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Anuh Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Anuh Pharma Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 34.9%21.6%16.3%20.6%10.9%19.8%19.3%21.1%29.7%19.8%-
Value Creation
Index
1.50.50.20.5-0.20.40.40.51.10.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 326206238321307432487527647662730
Sales YoY Gr.--36.8%15.5%34.7%-4.3%40.7%12.7%8.4%22.7%2.2%-
Adj EPS 2.71.91.52.51.82.33.13.75.84.73.9
YoY Gr.--29.2%-20.6%63.6%-27%26.6%31.8%19.9%57.3%-18.5%-
BVPS (₹) 11.91414.916.416.21921.324.129.132.532.6
Adj Net
Profit
27.519.415.425.318.523.430.736.95847.339
Cash Flow from Ops. 16.526.11.87.148.9-18.728.953.912.937.1-
Debt/CF from Ops. 0.101.30.60.9-0.70.100.20.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.2%16.6%10.8%2.2%
Adj EPS 6.2%20.7%15.4%-18.5%
BVPS11.8%15%15.1%11.9%
Share Price 0.8% 3.3% 20.4% -24%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2514.910.616.111.313.315.216.221.815.311.9
Op. Profit
Mgn %
12.3118.610.81010.510.110.211.89.77.6
Net Profit
Mgn %
8.49.46.57.965.46.3797.15.3
Debt to
Equity
00000.30.100000
Working Cap
Days
11617615313916915316216615316789
Cash Conv.
Cycle
3358625447325048506048

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Anuh Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 3.9 -
TTM Sales (₹ Cr.) 730 -
BVPS (₹.) 32.6 -
Reserves (₹ Cr.) 277 -
P/BV 2.43 -
PE 20.49 -
From the Market
52 Week Low / High (₹) 74.03 / 121.00
All Time Low / High (₹) 0.02 / 132.50
Market Cap (₹ Cr.) 793
Equity (₹ Cr.) 50.1
Face Value (₹) 5
Industry PE 40.7

Management X-Ray of Anuh Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Anuh Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Anuh Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales326206238321307432487527647662
Operating Expenses 289183220291284387439476571600
Manufacturing Costs18161620212527354146
Material Costs247149180241229328375399484496
Employee Cost 77910131415171923
Other Costs 17111519212021252734
Operating Profit 38231830234547527662
Operating Profit Margin (%) 11.5%11.0%7.7%9.3%7.6%10.4%9.8%9.8%11.7%9.3%
Other Income 487541156129
Interest 1101122111
Depreciation 2222715121099
Exceptional Items 0000000000
Profit Before Tax 38282332193939477861
Tax 128795109111814
Profit After Tax 26201723142831366047
PAT Margin (%) 7.9%9.7%6.9%7.3%4.7%6.6%6.3%6.9%9.3%7.2%
Adjusted EPS (₹)2.62.01.72.31.42.83.13.66.04.7
Dividend Payout Ratio (%)24%31%42%29%48%26%29%28%21%16%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 119141150165162191214241291326
Share Capital 13131313132525252525
Reserves 107128137152150166189216266301
Minority Interest0000000000
Debt2024451430210
Long Term Debt0000000000
Short Term Debt2024451430210
Trade Payables52425259105120122153141157
Others Liabilities 1854111589101211
Total Liabilities 191187208239326333347404445505

Fixed Assets

Gross Block331920279698100100104120
Accumulated Depreciation15245122738475562
Net Fixed Assets 18171721847161534958
CWIP 00634000000
Investments 437066398031439197106
Inventories24303243618180737574
Trade Receivables7557717581107136171190216
Cash Equivalents 136811320167820
Others Assets 187817182111102530
Total Assets 191187208239326333347404445505

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 16262749-1929541337
PBT 38282332193939477861
Adjustment -1-5-2-28784-30
Changes in Working Capital -811-13-1327-55-916-44-13
Tax Paid -13-8-7-10-5-10-9-13-19-11
Cash Flow From Investing Activity -5-2023-7752-8-431-20
Capex -11-1-7-29-36-6-1-1-5-20
Net Investments 3-23629-4356-9-445-1
Others 3433322211
Cash Flow From Financing Activity -9-4-5-722-33-19-12-9-5
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -0-0-0-0-1-2-1-0-0-0
Dividend Paid -11-2-8-8-170-8-9-10-13
Others 2-22239-32-11-328
Net Cash Flow 22-13-502-2512

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)23.4415.4311.3814.878.7516.1215.1115.922.5615.34
ROCE (%)34.9121.6116.3120.5610.8719.7519.3321.0529.6619.77
Asset Turnover Ratio1.91.151.231.441.121.341.441.411.531.4
PAT to CFO Conversion(x)0.621.30.120.33.5-0.680.941.50.220.79
Working Capital Days
Receivable Days761109682897890106101111
Inventory Days21454642605960534241
Payable Days741159684131125117125111109

Anuh Pharma Ltd Stock News

Anuh Pharma Ltd FAQs

The current trading price of Anuh Pharma on 05-Dec-2025 14:26 is ₹82.37.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Anuh Pharma stood at ₹793.4.
The latest P/E ratio of Anuh Pharma as of 04-Dec-2025 is 20.49.
The latest P/B ratio of Anuh Pharma as of 04-Dec-2025 is 2.43.
The 52-week high of Anuh Pharma is ₹121.0 and the 52-week low is ₹74.03.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Anuh Pharma is ₹730.0 ( Cr.) .

About Anuh Pharma Ltd

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506

Products

  • Macrolides
  • Higher Macrolides
  • Quinolones
  • Chloramphenicol
  • Anti TB Drug
  • Corticosteroids

Recognitions/Certifications

  • Anuh Pharma has received ‘Star Export House’ certification from the Ministry of Commerce and Industry.
  • The company received WHO-GMP certificate for carrying good manufacturing practices.
  • Anuh Pharma has received  ISO 9001:2000 certification
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×